651 Results
Guidelines and Advice
Status: Current
ID: GL-C50-24
Version: 3
ID: GL-C50-24
Version: 3
Jan 2024
Guidelines and Advice
Status: Current
ID: GL-C50-32
ID: GL-C50-32
Jan 2021
Guidelines and Advice
Status: Current
ID: 15-15
ID: 15-15
Sep 2017
Symptom Management
Symptom Management
Symptom Management
Drug
Other Name(s): Suprefact®
, Suprefact Depot®
, Suprefact Nasal Spray®
Nov 2024
Drug
Other Name(s): Neulasta®
, Lapelga™
, Fulphila™
, Ziextenzo®
, Nyvepria™
Dec 2022
Drug
Apr 2023
Drug
Jun 2019
Drug
Feb 2024